Envista Holdings Corp
General ticker "NVST" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $3.3B (TTM average)
Envista Holdings Corp follows the US Stock Market performance with the rate: 65.4%.
Estimated limits based on current volatility of 2.0%: low 28.04$, high 29.03$
Factors to consider:
- Total employees count: 12300 as of 2024
- US accounted for 47.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Supply chain disruptions, Regulatory and compliance, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.29$, 29.96$]
- 2026-12-31 to 2027-12-31 estimated range: [17.35$, 28.96$]
Financial Metrics affecting the NVST estimates:
- Positive: with PPE of 18.3 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 8.30
- Positive: 6.64 < Operating cash flow per share per price, % of 7.46
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.82
- Negative: Industry earnings per price (median), % of 0.69 <= 4.49
- Negative: Investing cash flow per share per price, % of -1.38 <= -0.63
- Negative: negative Industry operating cash flow (median)
- Negative: 0.73 < Interest expense per share per price, % of 0.99
Short-term NVST quotes
Long-term NVST plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,566.50MM | $2,510.60MM | $2,719.50MM |
| Operating Expenses | $2,535.00MM | $3,548.80MM | $2,493.80MM |
| Operating Income | $31.50MM | $-1,038.20MM | $225.70MM |
| Non-Operating Income | $-86.40MM | $-46.50MM | $-48.50MM |
| Interest Expense | $63.40MM | $46.40MM | $36.60MM |
| R&D Expense | $93.80MM | $99.10MM | $114.00MM |
| Income(Loss) | $-54.90MM | $-1,084.70MM | $177.20MM |
| Taxes | $45.30MM | $33.90MM | $130.20MM |
| Profit(Loss)* | $-100.20MM | $-1,118.60MM | $47.00MM |
| Stockholders Equity | $4,173.90MM | $2,934.80MM | $3,106.30MM |
| Inventory | $258.80MM | $241.00MM | $288.10MM |
| Assets | $6,605.10MM | $5,350.50MM | $5,679.00MM |
| Operating Cash Flow | $275.70MM | $336.50MM | $275.70MM |
| Capital expenditure | $58.20MM | $33.80MM | $45.30MM |
| Investing Cash Flow | $-62.40MM | $-54.60MM | $-51.10MM |
| Financing Cash Flow | $118.90MM | $-103.70MM | $-170.90MM |
| Earnings Per Share** | $-0.60 | $-6.50 | $0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.